Taking this a step further, a recently published JAMA study of middle-aged adults with ADHD found that the use of ADHD medications was associated with a 10% lower risk of long-term unemployment, especially for women.

When you look at this with other data in mind, the need for proper—and earlier—diagnosis of women and gender-diverse individuals becomes even more apparent. ADHDers, as a whole, earn 17% less than their neurotypical counterparts and also have higher unemployment rates. According to a 2023 Pew Research Center article, in 2022, American women earned 82% of what men did. It’s not hard to connect the dots and figure out that ADHD women are, therefore, earning even less than men. When you take into account other intersectional identities such as race, ethnicity, sexual orientation, and other disabilities, based upon data, it’s not hard to extrapolate that that pay gap only continues to increase.

So what can we do about it? First, the article from Attitude outlines significant first steps—stop looking at ADHD only through the male lens and start realizing that women and gender-diverse individuals present differently. Second, once diagnosed, access to medication (for those who want to take medication and who can take medication, as not everyone can, and it’s a very personal choice) and destigmatization of medication are paramount. Third, employers need to realize that while ADHD comes with its challenges, it also comes with positives, and when we’re allowed to work WITH our brains rather than against them, magical things can happen.

#ADHD #Neurodiversity #Neurodivergent #NeurodiversityAtWork #GenderBias

To learn more about this post on LinkedIn, click here.

To follow Aubrey Gross, this is her LinkedIn.

She is referring to this post in ADDidude Magazine.